These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2543088)
1. New strategy for treatment of carcinoma of the hilar bile duct. Koyama K; Tanaka J; Kato S; Asanuma Y Surg Gynecol Obstet; 1989 Jun; 168(6):523-30. PubMed ID: 2543088 [TBL] [Abstract][Full Text] [Related]
2. Experience in twenty patients with carcinoma of hilar bile duct treated by resection, targeting chemotherapy and intracavitary irradiation. Koyama K; Tanaka J; Sato Y; Seki H; Kato Y; Umezawa A Surg Gynecol Obstet; 1993 Mar; 176(3):239-45. PubMed ID: 8438195 [TBL] [Abstract][Full Text] [Related]
3. Intracavitary irradiation treatment via the inferior vena cava for caudate lobe invasion in hepatic hilar bile duct cancer. Koyama K; Tanaka J; Sato Y; Kato S; Asanuma Y; Kato T Hepatogastroenterology; 1991 Oct; 38(5):422-6. PubMed ID: 1765360 [TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of hilar carcinoma of the bile duct. Mizumoto R; Kawarada Y; Suzuki H Surg Gynecol Obstet; 1986 Feb; 162(2):153-8. PubMed ID: 3945893 [TBL] [Abstract][Full Text] [Related]
6. Surgical treatment and postoperative outcomes for middle and lower bile duct carcinoma in Japan--experience of a single institute. Suzuki M; Unno M; Oikawa M; Endo K; Katayose Y; Matsuno S Hepatogastroenterology; 2000; 47(33):650-7. PubMed ID: 10919005 [TBL] [Abstract][Full Text] [Related]
7. Targeting chemotherapy for intrahepatic periductal lymphatic invasion by mitomycin C adsorbed to activated charcoal in hepatic hilar bile duct cancer. Koyama K; Kato S; Tanaka J; Asanuma Y; Sato Y Am J Surg; 1989 Jul; 158(1):8-13. PubMed ID: 2742051 [TBL] [Abstract][Full Text] [Related]
8. Role of hepatectomy in the treatment of hilar bile duct carcinoma. Tsuchikawa T; Kondo S; Hirano S; Tanaka E; Anbo Y; Morikawa T; Okushiba S; Katoh H Surg Today; 2004; 34(5):405-8. PubMed ID: 15108077 [TBL] [Abstract][Full Text] [Related]
9. Surgical management of hilar bile duct cancer. Preoperative diagnosis, selection of treatment options and clinical outcome. Hirai I; Kimura W; Fuse A; Suto K; Sakurai F; Ishiyama S Hepatogastroenterology; 2003; 50(51):629-35. PubMed ID: 12828048 [TBL] [Abstract][Full Text] [Related]
10. Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma. Matsumoto S; Kiyosue H; Komatsu E; Wakisaka M; Tomonari K; Hori Y; Matsumoto A; Mori H Cancer; 2004 Jun; 100(11):2422-9. PubMed ID: 15160347 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091 [TBL] [Abstract][Full Text] [Related]
12. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications. Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836 [TBL] [Abstract][Full Text] [Related]
13. [Intra-arterial and intraportal therapy combined with decollateralization in unresectable cholangiocellular carcinoma--a case report]. Wada H; Sasaki Y; Imaoka S; Shibata T; Nagano H; Ishikawa O; Ohigashi H; Furukawa H; Fukuda I; Kabuto T Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2867-70. PubMed ID: 2551229 [TBL] [Abstract][Full Text] [Related]
14. Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma. Shimada H; Endo I; Fujii Y; Kunihiro O; Tanaka K; Misuta K; Togo S Hepatogastroenterology; 2002; 49(44):300-5. PubMed ID: 11995438 [TBL] [Abstract][Full Text] [Related]
15. [Low-dose cisplatin plus 5-fluorouracil with radiotherapy for unresectable upper and hilar bile duct carcinoma]. Oda A; Katayose Y; Rikiyama T; Oikawa M; Yamamoto K; Hayashi H; Unno M Gan To Kagaku Ryoho; 2005 Oct; 32(11):1615-7. PubMed ID: 16315887 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and surgical features of Klatskin tumors. Santoro E; Sacchi M; Carboni F; Santoro R; Scardamaglia F Chir Ital; 1999; 51(1):1-7. PubMed ID: 10514910 [TBL] [Abstract][Full Text] [Related]
17. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T; Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440 [TBL] [Abstract][Full Text] [Related]
19. Carcinoma of the gallbladder: an appraisal of surgical resection. Chijiiwa K; Tanaka M Surgery; 1994 Jun; 115(6):751-6. PubMed ID: 7910985 [TBL] [Abstract][Full Text] [Related]
20. Surgical treatment for proximal bile duct carcinoma. Kusano T; Tamai O; Miyazato H; Isa T; Shiraishi M; Muto Y; Furukawa M Int Surg; 1998; 83(2):119-23. PubMed ID: 9851327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]